Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; purified talc - olmetec is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; purified talc - olmetec is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; hyprolose; lactose monohydrate; titanium dioxide; hypromellose; purified talc - olmetec is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; hyprolose; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; purified talc; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; purified talc; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; lactose monohydrate; hyprolose; titanium dioxide; hypromellose; iron oxide yellow; purified talc; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - olmesartan medoxomil -

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - olmesartan medoxomil; hydrochlorothiazide -

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - hydrochlorothiazide; olmesartan medoxomil - tablet, film coated - 12.50 mg - hydrochlorothiazide 12.50 mg; olmesartan medoxomil 20.00 mg

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - hydrochlorothiazide; olmesartan medoxomil - tablet, film coated - 25.00mg - hydrochlorothiazide 25.00mg; olmesartan medoxomil 40.00mg